RE: Results19 Feb 2019 10:03
I didn't have time to have a proper look at the presentation and interims yesterday. I found the dividend policy in the Corporate Governance Tab of the website, but it's what's stated in the presentation. A bit disappointed by lack of clarity, however a few other things jump out from the Interims that are positive:
1) Forecasted "base case" EBITDA has gone up to $40million for FY 2020, 2021 & 2022, based on much lower Palladium & Rhodium price than we are experiencing. Considering they have no debt and very little Capex in these years (see below), for once a Company's EBITDA's will be close to its actual free cashflow (of course have to take into account Corp Income Tax of 28%).
2) Forecast Capex has decreased for these years, with forecast of $8m FY 2020 and $3m for 2021 & 2022
3) Guidance reduced slightly to 73,000 - 76,000 Oz for FY 2019, meaning for 6 months to June 2019, to meet lower target output would need to be 39,000 Oz, which would be very good outcome.
4) There's a fair bit of Capex to get through these next 6 months to June 2019 (est. $8million), which may explain why dividend policy is still quite high level and cash generation for next 6 months may be limited. But thereafter as per item 2) above, Capex drops off considerably.
5) Cash + Trade Balance (Receivables minus Payables) is $38.5million (half the market cap). This coupled with the cash generation going forward & life of production, SLP remains grossly undervalued in my opinion. If they sort out the dividend policy properly come June 2019 and make it clearer what all this cash is going to be doing, particularly 2x dividends per year, it should start to realise its true value.